Related Experiment Video
Updated: Aug 5, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-like receptors in infectious myocarditis: pathogen-specific recognition, spatiotemporal dynamic regulation and
Yuhua Li1, Weiming Liao2, Qingfei Liang3
1Department of Pharmacy, The First Naval Hospital of Southern Theatre Command, Zhanjiang, Guangdong, China.
Insights
Toll-like receptor (TLR) activation dictates infectious myocarditis severity and progression. Understanding pathogen-TLR matching and TLR signaling dynamics is crucial for developing targeted therapies and improving patient outcomes.
Area of Science:
- Cardiovascular Immunology
- Infectious Diseases
- Innate Immunity
Background:
- Infectious myocarditis presents diverse clinical outcomes and high mortality rates, influenced by causative agents like COVID-19, influenza, and sepsis.
- Toll-like receptors (TLRs) are central to innate immunity, orchestrating inflammatory responses from pathogen recognition to chronic tissue remodeling in myocarditis.
- Current research often overlooks the specific pathogen-TLR interactions and the dynamic, time-dependent regulation of TLR signaling throughout myocarditis progression.
Purpose of the Study:
- To systematically review the epidemiological data of infectious myocarditis.
- To elucidate the role of Toll-like receptor (TLR) family signaling in the cardiac immune microenvironment during disease progression.
- To analyze pathogen-specific TLR recognition and the spatiotemporal regulation of TLR signaling pathways.
Main Methods:
- Comprehensive literature review of epidemiological profiles and clinical data on infectious myocarditis.
- Analysis of TLR expression patterns and signaling mechanisms within the cardiac immune milieu.
- Examination of pathogen-specific recognition modes and TLR signaling dynamics across different disease stages (acute inflammation, immune deviation, chronic fibrosis).
Main Results:
- Pathogen-TLR matching is a key determinant of inflammatory phenotypes and disease severity in infectious myocarditis.
- The spatiotemporal dynamics of TLR signaling critically govern the progression of myocarditis.
- Effective TLR-targeted therapies require pathogen specificity and precise, stage-specific regulation.
Conclusions:
- Pathogen-TLR interactions and the dynamic regulation of TLR signaling are fundamental to understanding infectious myocarditis.
- This review provides a theoretical framework for precise immunodiagnosis and individualized immunotherapy strategies for infectious myocarditis.
- Targeting TLRs necessitates a nuanced approach considering pathogen type and disease stage for optimal therapeutic outcomes.
Abstract:
Infectious myocarditis is a life-threatening cardiovascular inflammatory disorder characterized by high heterogeneity in clinical onset, progression and prognosis. Large-sample clinical data have demonstrated that the in-hospital mortality of COVID-19-associated myocarditis reaches 19.4%, significantly higher than that of influenza-associated myocarditis (10.5%). Additionally, the incidence of adeno-associated virus (AAV) gene therapy-related myocarditis is 6.2%, while the mortality of sepsis-associated myocarditis is as high as 70%-90%. Toll-like receptors (TLRs), the core pattern recognition receptors of innate immunity, dominate the entire pathological cascade, ranging from pathogen recognition and acute inflammatory burst to myocardial injury and chronic fibrous remodeling. Nevertheless, most current studies merely focus on the linear correlation between individual TLR activation and myocardial inflammation, failing to systematically clarify pathogen-TLR matching specificity and the spatiotemporal dynamic regulatory mechanisms of TLR signaling throughout disease progression. This review comprehensively combs the latest epidemiological profiles of infectious myocarditis, characterizes the expression patterns and signaling regulatory features of the TLR family within the cardiac immune microenvironment, analyzes pathogen-specific recognition modes mediated by common pathogens, elaborates the spatiotemporal regulatory rules of TLR signaling across acute inflammation, immune deviation and chronic fibrosis stages, and summarizes pathogen-oriented intervention strategies as well as relevant translational bottlenecks. Cumulative clinical evidence confirms that pathogen-TLR matching determines inflammatory phenotypes and severity of infectious myocarditis, and that the spatiotemporal dynamics of TLR signaling directly govern disease progression. Notably, TLR-targeted therapies must adhere to the core principles of pathogen specificity and staged precise regulation. This review provides a systematic theoretical basis for precise immunodiagnosis and individualized immunotherapy of infectious myocarditis.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management

